Ebstein's AnomalySymptoms, Doctors, Treatments, Advances & More
Ebstein's Anomaly Overview
Learn About Ebstein's Anomaly
- Ebstein's anomaly
- Ebstein anomaly
- Ebstein's malformation
UPMC Children's Hospital Of Pittsburgh, Pediatric Cardiac Surgery
Dr. Luciana da Fonseca da Silva is a pediatric cardiothoracic surgeon. Dr. da Fonseca da Silva earned her medical degree from Federal University of Juiz de Fora and her doctoral degree from Federal University of Sao Paulo. She completed a residency and fellowship at Beneficencia Portuguesa Hospital. Dr. Silva is rated as an Elite provider by MediFind in the treatment of Ebstein's Anomaly. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Ebstein's Anomaly, Hypoplastic Left Heart Syndrome (HLHS), Tricuspid Regurgitation, and Transposition of the Great Arteries. Dr. Silva is currently accepting new patients.
MN - Heart Congenital
Heidi Connolly is a Cardiologist practicing medicine in Rochester, Minnesota. Dr. Connolly is rated as an Elite provider by MediFind in the treatment of Ebstein's Anomaly. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Ebstein's Anomaly, Coarctation of the Aorta, Congenital Heart Disease (CHD), Heart Transplant, and Cardiac Ablation.
Boston Childrens Heart Foundation Inc
Wayne Tworetzky is a Pediatrics provider practicing medicine in Boston, Massachusetts. Dr. Tworetzky is rated as an Elite provider by MediFind in the treatment of Ebstein's Anomaly. He is also highly rated in 60 other conditions, according to our data. His clinical expertise encompasses Ebstein's Anomaly, Hypoplastic Left Heart Syndrome (HLHS), Pulmonary Atresia, and Congenital Heart Disease (CHD).
Summary: Ebstein anomaly and tricuspid valve dysplasia (EA/TVD) are rare congenital tricuspid valve malformations that carry among the highest mortality of all congenital heart disease diagnosed in utero. Despite the high mortality associated with severe EA/TVD in the fetus, it has only been studied retrospectively. By prospectively enrolling a cohort across multiple centers, many questions may be answered...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
